FDA approves temporary import of sodium bicarbonate injection due to shortage

AHA News Now

The Food and Drug Administration recently authorized the temporary import of a sodium bicarbonate injection product from Australia to address a critical shortage of the drug, commonly used in hospitals to treat a chemical imbalance in the blood. Athenex Pharmaceutical Division will import and distribute the drug in 10 mL and 100 mL vials. Pfizer recently reported shortages of several injectable drugs used in hospitals and other clinical settings, including sodium bicarbonate injection and emergency drug syringes. FDA is working with manufacturers to resolve these and other injectable drug shortages.

Topic: Advocacy and Public Policy
Tag: Drug Shortages

Keyword Search

Date